Iradimed Corporation
(NASDAQ) IRMD
Iradimed Corporation Financials at a Glance
Market Cap
$1.24B
Revenue (TTM)
$83.81M
Net Income (TTM)
$22.48M
EPS (TTM)
$1.75
P/E Ratio
55.66
Dividend
$0.71
Beta (Volatility)
0.91 (Low)
Dividend
$0.71
Beta (Volatility)
0.91 (Low)
Price
$97.40
Volume
70,066.562
Open
$98.26
Price
$97.40
Volume
70,066.562
Open
$98.26
Previous Close
$97.36
Daily Range
$95.25 - $98.61
52-Week Range
$47.23 - $107.90
Dividend
$0.71
Beta (Volatility)
0.91 (Low)
Price
$97.40
Volume
70,066.562
Open
$98.26
Previous Close
$97.36
Daily Range
$95.25 - $98.61
52-Week Range
$47.23 - $107.90
IRMD News
Why Iradimed Stock Soared Today
IRMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Iradimed Corporation
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
166
CEO
Roger Susi
Website
www.iradimed.comHeadquarters
Winter Springs, FL 32708, US
IRMD Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
31%
Net Income Margin
27%
Return on Equity
25%
Return on Capital
27%
Return on Assets
21%
Earnings Yield
1.80%
Dividend Yield
0.01%
Payout Ratio
66.90%
Stock Overview
Market Cap
$1.24B
Shares Outstanding
12.78M
Volume
70.07K
Short Interest
0.00%
Avg. Volume
74.08K
Financials (TTM)
Gross Profit
$64.32M
Operating Income
$26.15M
EBITDA
$28.53M
Operating Cash Flow
$24.95M
Capital Expenditure
$7.76M
Free Cash Flow
$17.18M
Cash & ST Invst.
$51.16M
Total Debt
$0.00
Iradimed Corporation Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$22.69M
+17.0%
Gross Profit
$17.03M
+15.4%
Gross Margin
75.06%
N/A
Market Cap
$1.24B
N/A
Market Cap/Employee
$7.78M
N/A
Employees
160
N/A
Net Income
$6.44M
+25.2%
EBITDA
$7.71M
+17.9%
Quarterly Fundamentals
Net Cash
$51.16M
-1.8%
Accounts Receivable
$13.67M
+29.5%
Inventory
$11.62M
+11.7%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
20.67%
N/A
Return on Invested Capital
26.52%
N/A
Free Cash Flow
$5.44M
+85.7%
Operating Cash Flow
$5.92M
-1.1%